GLARIVIBART
UNII 2S8Z6KF7W9

Substance Identification & Data

This profile provides standardized clinical and technical data for Glarivibart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2S8Z6KF7W9.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3033697-08-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
2S8Z6KF7W9
CAS Registry Number
3033697-08-1
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
GLARIVIBART
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C224745
National Cancer Institute reference terminology for clinical and research data.
INN ID
13605
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Glarivibart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

GLARIVIBART

Common Names & Synonyms

GLARIVIBART [INN]
H-GAMMA1 HEAVY CHAIN HOMO SAPIENS (1-456) (VH (HOMO SAPIENS IGHV1-69*01 (87.6%) -(IGHD) -IGHJ4*01 (86.7%), CDR-IMGT (8.8.19) (26-33.51-58.97-115)) (1-126) -HOMO SAPIENS IGHG1*03, G1M3, NG1M1 CH1 R120, CH3 E12, M14, 9-G1V21 CH2 Y15.1, T16, E18(CH1 R120 (223) (127-224), HINGE 1-15 (225-239), CH2 M15.1>Y (261), S16>T (263), T18>E (265) (240-349), CH3 E12 (365), M14 (367) (350-454), CHS (455-456)) (127-456)), (229-214')-DISULFIDE WITH L-KAPPA LIGHT CHAIN HOMO SAPIENS (1'-214') (V-KAPPA (HOMO SAPIENS IGKV1-33*01 (93.6%) -IGKJ4*01 (91.7%), CDR-IMGT (6.3.9) (27'-32'.50'-52'.89'-97')) (1'-107') -HOMO SAPIENS IGKC*01 (100%) KM3 A45.1, V101 (C-KAPPA A45.1 (153'), V101 (191')) (108'-214')); DIMER (235-235'':238-238'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, GLYCOFORM ALFA
IMMUNOGLOBULIN G1 (261-TYROSINE,263-THREONINE,265-GLUTAMIC ACID), ANTI-(RESPIRATORY SYNCYTIAL VIRUS F PROTEIN) (HUMAN MONOCLONAL GR2102 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL GR2102 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) FUSION GLYCOPROTEIN F), HOMO SAPIENS MONOCLONAL ANTIBODY (GLARIVIBART)

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus